Kalshi Will Offer Sports-Style Betting on Drug Trial Results
Prediction platform Kalshi is launching sports-style betting markets focused on biotech clinical trials and FDA drug approvals.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
Kalshi has introduced a pilot program for biotech prediction markets. This initiative allows users to place wagers on the outcomes of clinical trials and the status of drug approvals.
Coverage from Bloomberg, STAT, Seeking Alpha, and Kalshi News emphasizes the application of sports-style betting to the biopharma sector. Reports specifically mention the platform's focus on clinical trials and FDA approvals, with STAT noting a Merck cholesterol pill as a point of interest.
Future developments depend on the progression of this pilot program and the specific drug trials targeted for prediction markets.
Synthesized by Archynetys from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 1h ago.
Quick answers
What is Kalshi offering?
Kalshi is launching a pilot program for biotech prediction markets involving wagers on clinical trials and drug approvals.
Which specific drug is mentioned in the coverage?
STAT mentions a Merck cholesterol pill in relation to Kalshi bets.
Who is reporting on this trend?
The trend is being covered by Bloomberg, STAT, Seeking Alpha, and Kalshi News.
Coverage (7)
- Kalshi to offer betting on drug trial results and FDA regulatory decisions The Guardian · 6h ago
- Kalshi to allow bets on clinical trials, FDA decisions Reuters · 6h ago
- Pharmalittle: We're reading about Kalshi bets on clinical trials, a Merck cholesterol pill, and more STAT · 6h ago
- Kalshi offers wagers on clinical trials and drug approvals Seeking Alpha · 6h ago
- Kalshi launches biotech prediction markets pilot program Kalshi News · 6h ago
- Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvals STAT · 6h ago
- Kalshi Will Offer Sports-Style Betting on Drug Trial Results Bloomberg.com · 6h ago
Topics
Related trends
The F.D.A. Approves a New Pill to Slash Cholesterol Levels
The FDA has approved a first-of-its-kind cholesterol pill from Merck designed to drive cholesterol levels lower than statins.
US FDA sued for allowing unauthorized vaping products
Public health organizations are suing the FDA to block policies that allow the sale of unauthorized flavored vaping products.
Kalshi traders see gas prices crossing $4 by end of July
Prediction markets and rising oil costs signal a potential surge in gas prices, with some traders eyeing a $4 threshold by the end of July.
Why This Biotech Stock, With Its First FDA Approval, Just Crashed By Double Digits
Celcuity shares plummeted by double digits despite the FDA approval of its first breast cancer drug, Revtorpyk.
An experimental Alzheimer's drug shows some promise as researchers hunt new approaches
Biogen faces a mixed market reception as new trial data for its tau-targeting Alzheimer's drug shows both promise and significant unanswered questions.
FDA releases 14 drug rejection letters after 3-month pause
The FDA has resumed the release of Complete Response Letters (CRLs) after a three-month disclosure freeze, issuing 14 new drug rejection notices.